Today’s Solutions: October 03, 2024

Myeloma multiplex leukemia cancer 3d color render illustration

Novel blood cancer treatment effective in three-fourths of trial patients

According to new findings from an ongoing Phase 1/2 clinical research trial, a novel investigational immunotherapy resulted in successful response rates for 73 percent of patients with multiple myeloma, a lethal form of blood cancer. Based on these encouraging findings, an application to the US Read More...